In gastric cancer under hyperglycemic conditions, it attenuated fructose-induced cytoskeletal rearrangement, cell migration, and E-cadherin repression by interfering with the polyol pathway–driven activation of the KHK-A–YWHAH–SLUG axis [49]. The gene discussed is SNAI2; the disease is gastric cancer.